81 results match your criteria: "Michallon University Hospital[Affiliation]"
Tech Coloproctol
March 2019
Colorectal Unit, Department of Surgery, Michallon University Hospital, CS 10 217, 38 043, Grenoble cedex, France.
Background: The over-the-scope clip proctology system is rather new and information regarding its use for the closure of anorectal fistulas is scarce. No study has been designed to focus exclusively on its application in the treatment of rectovaginal fistulas. The aim of the study was to evaluate the feasibility, safety, and effectiveness of the clip for rectovaginal fistula repair.
View Article and Find Full Text PDFAnn Intensive Care
January 2019
Medical ICU, Saint-Louis Teaching Hospital, 1 Avenue Claude Vellefaux, 75010, Paris, France.
Background: Although outcomes of critically ill patients with haematological malignancies (HMs) have been fully investigated in terms of organ failure and mortality, data are scarce on health-related quality of life (HRQOL) in this population. We aim to assess post-intensive care unit (ICU) burden and HRQOL of critically ill patients with HMs and to identify risk factors for quality-of-life (QOL) impairment.
Results: In total, 1011 patients with HMs who required ICU admission in 17 ICUs in France and Belgium were included in the study; 278 and 117 patients were evaluated for QOL at 3 months and 1 year, respectively, after ICU discharge.
Tech Coloproctol
October 2018
Colorectal Unit, Department of Surgery, Michallon University Hospital, Grenoble, CS 10217, 38043, Grenoble Cedex, France.
Leuk Lymphoma
May 2019
a Medical ICU , Saint-Louis Teaching Hospital, Paris , France.
In patients with hematologic malignancies, respiratory status may deteriorate during neutropenia recovery. This multicenter, observational study aims to evaluate granulocyte colony-stimulating factor (G-CSF) impact on respiratory status in critically ill neutropenic patients. Among 1011 critically ill patients with hematologic malignancies, 288 were neutropenic and included in this study.
View Article and Find Full Text PDFJ Visc Surg
April 2019
Department of Surgery, Colorectal Unit, Michallon University Hospital, 38000 Grenoble, France; University Grenoble Alps, UMR 5525, CNRS, TIMC-IMAG, 38000 Grenoble, France.
Tech Coloproctol
July 2018
Colorectal Unit, Department of Surgery, Michallon University Hospital, Grenoble, France.
Background: Surgical treatment for low rectal cancer septic complications often requires an ileostomy for fecal diversion. Delayed coloanal anastomosis (CAA) has been performed for several years to reduce septic complications and to avoid ileostomy. The aim of this study was to report the technical, functional and oncological results of delayed CAA in patients operated on for low rectal cancer focusing on pelvic septic complications.
View Article and Find Full Text PDFIntensive Care Med
July 2018
UMR 1137, IAME Team 5, DeSCID: Decision SCiences in Infectious Diseases, Control and Care, INSERM, Paris Diderot, Sorbonne Paris Cité University, Paris, France.
The members of the OUTCOMEREA Study Group were provided in such a way that they could not be indexed as collaborators on PubMed. The publisher apologizes for this error and is pleased to list the members of the group here.
View Article and Find Full Text PDFN Engl J Med
June 2018
From the Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis, Hepatology and Gastroenterology Department, Saint-Antoine University Hospital, Assistance Publique-Hôpitaux de Paris (APHP) (C.C., O.C., S.L., F.G., R.P.), INSERM Unité Mixte de Recherche (UMR) S938 (C.C., O.C., S.L., R.P.) and the Biochemistry Laboratory (L.H., D.R.), Saint-Antoine University Hospital, APHP, INSERM Unité 1157/UMR 7203, Sorbonne University, the Biochemistry Laboratory, Tenon University Hospital, APHP (G.L.), and the Immunology Laboratory, INSERM UMR S996, Bichat University Hospital, APHP (L.C., S.C.-M.), Paris-Sud University, the Department of Clinical Pharmacology and Clinical Research Platform of the East of Paris, APHP (A.R., F.-H.A., T.S.), and Sorbonne University (T.S.), Paris, the Hepatology and Gastroenterology Department, Rouen University Hospital, Rouen (O.G.), the Hepatology and Gastroenterology Department, Pontchaillou University Hospital, Rennes (A.L.G.), the Hepatology and Gastroenterology Department, University Hospitals of Strasbourg, Institute of Viral and Liver Diseases, INSERM Unité 1110, Laboratory of Excellence HepSYS, University of Strasbourg, Strasbourg (F.H.), the Hepatology and Gastroenterology Department, Claude Huriez University Hospital, Lille (P.M.), the Hepatology and Gastroenterology Department, Orleans Hospital, Orleans (P.P.), the Hepatology and Gastroenterology Department, Dijon Bourgogne University Hospital, Dijon (A.M.), the Hepatology and Gastroenterology Department, University Hospital of Poitiers, Poitiers (C.S.), the Hepatology and Gastroenterology Department, Estaing University Hospital, Clermont-Ferrand (A.A.), the Hepatology and Gastroenterology Department, University Hospital of Limoges, Limoges (M.D.-G.), the Hepatology and Gastroenterology Department, Saint-Eloi University Hospital, Montpellier (D.L.), the Hepatology Department, Beaujon University Hospital, Clichy (O.R.), the Hepatology and Gastroenterology Department, Brabois University Hospital, Nancy (J.-P.B.), the Hepatology and Gastroenterology Department, University Hospital of Angers, Hemodynamics, Interaction, Fibrosis, and Tumor Invasiveness in Hepatic and Digestive Organs Laboratory, Unité Propre de Recherche de l'Enseignement Supérieur 3859, Structures Fédératives de Recherche 4208, Bretagne Loire University, Angers (J.B.), the Hepatology and Gastroenterology Department, Haut-Lévêque University Hospital, Pessac (V.L.), the Hepatology and Gastroenterology Department, Robert Debré University Hospital, Reims (A.H.-B.), the Hepatology and Gastroenterology Department, University Hospital of Amiens, Amiens (E.N.-K.), the Hepatology and Gastroenterology Department, Croix-Rousse University Hospital, Lyon (F.Z.), the Hepatology and Gastroenterology Department, University Hospital of Caen, Caen (I.O.-H.), the Hepatology and Gastroenterology Department, Michallon University Hospital, Grenoble (J.-P.Z.), and the Hepatology and Gastroenterology Department, Jean Verdier University Hospital, Bondy (G.N.) - all in France.
Background: Patients with primary biliary cholangitis who have an inadequate response to therapy with ursodeoxycholic acid are at high risk for disease progression. Fibrates, which are agonists of peroxisome proliferator-activated receptors, in combination with ursodeoxycholic acid, have shown potential benefit in patients with this condition.
Methods: In this 24-month, double-blind, placebo-controlled, phase 3 trial, we randomly assigned 100 patients who had had an inadequate response to ursodeoxycholic acid according to the Paris 2 criteria to receive bezafibrate at a daily dose of 400 mg (50 patients), or placebo (50 patients), in addition to continued treatment with ursodeoxycholic acid.
Tech Coloproctol
May 2018
Colorectal Unit, Department of Surgery, Michallon University Hospital, CS 10217, 38043, Grenoble cedex, France.
J Gastrointest Surg
March 2019
Colorectal Unit, Department of Surgery, Grenoble Alps University Hospital, 38000, Grenoble, France.
Intensive Care Med
May 2018
UMR 1137, IAME Team 5, DeSCID: Decision SCiences in Infectious Diseases, Control and Care, INSERM, Paris Diderot, Sorbonne Paris Cité University, Paris, France.
Purpose: To investigate the clinical significance of infection-related ventilator-associated complications (IVAC) and their impact on carbapenem consumption in mechanically ventilated (MV) patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLE).
Methods: Inception cohort study from the French prospective multicenter OUTCOMEREA database (17 ICUs, 1997-2015) including all ESBLE carriers (systematic rectal swabbing at admission then weekly and/or urinary or superficial surgical site colonisation) with MV duration > 48 h and ≥ 1 episode of IVAC after carriage documentation. All ICU-acquired infections were microbiologically documented.
Background: Cardiac resynchronization therapy (CRT) is an effective treatment of heart failure (HF), but is limited by a substantial proportion of nonresponders. We hypothesized that adding a second left ventricular (LV) lead to deliver a triple-site CRT (V CRT) may improve clinical status of CRT nonresponders.
Objective: We assessed the feasibility and safety of adding a second LV lead to CRT nonresponders and its clinical impact.
Trials
November 2017
Infection, Antimicrobials, Modelling, Evolution (IAME), UMR 1137, INSERM and Paris Diderot University, Department of Biostatistics - HUPNVS - AP-HP, UFR de Médecine - Bichat University Hospital, Paris, France.
Background: Post-intensive care syndrome includes the multiple consequences of an intensive care unit (ICU) stay for patients and families. It has become a new challenge for intensivists. Prevention programs have been disappointing, except for ICU diaries, which report the patient's story in the ICU.
View Article and Find Full Text PDFDis Colon Rectum
September 2017
1 Colorectal Unit, Department of Surgery, Michallon University Hospital, Grenoble, France 2 University Grenoble Alps, UMR 5525, CNRS, TIMC-IMAG, Grenoble, France 3 Ambulatory Unit, Department of Surgery, Michallon University Hospital, Grenoble, France.
Tech Coloproctol
June 2017
Colorectal Unit, Ambulatory Unit, Department of Surgery, Michallon University Hospital, CS 10 217, 38 043, Grenoble Cedex, France.
Tech Coloproctol
May 2017
Colorectal Unit, Department of Surgery, Michallon University Hospital, CS 10217, 38043, Grenoble Cedex, France.
Tech Coloproctol
May 2017
Colorectal Unit, Department of Surgery, Michallon University Hospital, CS 10217, 38000, Grenoble, France.
J Visc Surg
December 2016
Colorectal Unit, Department of Surgery, Michallon University Hospital, 38000 Grenoble, France; University Grenoble Alps, UMR 5525, CNRS, TIMC-IMAG, 38000 Grenoble, France.
Tech Coloproctol
December 2016
Colorectal Unit, Department of Surgery, Michallon University Hospital, 38000, Grenoble, France.
J Infect
February 2017
INSERM, IAME, UMR 1137, Team DesCID, F-75018 Paris, France; Medical Intensive Care Unit, Assistance Publique des Hôpitaux de Paris (AP-HP), Bichat University Hospital, Paris, France.
Objectives: ICU-acquired bloodstream infection (ICUBSI) in Intensive Care unit (ICU) is still associated with a high mortality rate. The increase of antimicrobial drug resistance makes its treatment increasingly challenging.
Methods: We analyzed 571 ICU-BSI occurring amongst 10,734 patients who were prospectively included in the Outcomerea Database and who stayed at least 4 days in ICU.
J Gynecol Obstet Biol Reprod (Paris)
October 2016
Department of Digestive Physiology, Edouard Herriot University Hospital, 69000 Lyon, France.
JAMA
October 2016
UMR1137-IAME Inserm, Paris Diderot University, Paris, France2Medical and Infectious Diseases ICU, Bichat-Claude Bernard University Hospital, Paris, France.
Importance: Although frequently used in treating intensive care unit (ICU) patients with sepsis, empirical antifungal therapy, initiated for suspected fungal infection, has not been shown to improve outcome.
Objective: To determine whether empirical micafungin reduces invasive fungal infection (IFI)-free survival at day 28.
Design, Setting, And Participants: Multicenter double-blind placebo-controlled study of 260 nonneutropenic, nontransplanted, critically ill patients with ICU-acquired sepsis, multiple Candida colonization, multiple organ failure, exposed to broad-spectrum antibacterial agents, and enrolled between July 2012 and February 2015 in 19 French ICUs.
Ann Surg
November 2016
*Colorectal Unit, Institut des Maladies de l'Appareil Digestif (IMAD), University Hospital of Nantes, Nantes, France †Colorectal Unit, Department of Surgery, Michallon University Hospital, Grenoble, France ‡Colorectal Unit, Department of Surgery, University Hospital of Lille, Lille, France §Department of Proctology, University Hospital of Rennes, Rennes, France ¶Department of Digestive Surgery, Poissy Hospital, Saint-Germain en Laye, France ||Department of Digestive Surgery, Vichy Hospital, Vichy, France **Department of Surgery, University Hospital of Angers, Angers, France ††Unit of Methodology and Biostatistics, University Hospital of Nantes, Nantes, France ‡‡Health economics and health policy research unit, AP-HP Paris, France.
Objective: To compare Doppler-guided hemorrhoidal artery ligation (DGHAL) with circular stapled hemorrhoidopexy (SH) in the treatment of grade II/III hemorrhoidal disease (HD).
Background: DGHAL is a treatment option for symptomatic HD; existing studies report limited risk and satisfactory outcomes. DGHAL has never before been compared with SH in a large-scale multi-institutional randomized clinical trial.
Ann Surg
March 2017
*Colorectal Unit, Haut Lévêque Hospital, CHU Bordeaux, France †University of Bordeaux, Bordeaux, France ‡Surgical Oncology Department, Montpellier Cancer Institute (ICM), Val d'Aurelle, Montpellier, France §Colorectal Unit, Department of Surgery, Michallon University Hospital, Grenoble, France ¶University Grenoble Alpes, Grenoble, France ||Department of Colorectal Surgery, Beaujon Hospital (AP-HP), Paris VII University, Clichy, France **Department of Surgery, Pontchaillou University Hospital, Rennes, France ††Department of Digestive Surgery, Hospital Center Lyon-Sud, University of Lyon, Lyon, France ‡‡Department of Surgery, Hotel Dieu University Hospital, Nantes, France §§Department of Surgery, Purpan University Hospital, Toulouse, France ¶¶Department of Digestive and Oncological Surgery, Amiens Picardie University Hospital, Amiens, France ||||Inserm Unit, Picardie Jules-Verne University, Amiens, France ***Department of Digestive Surgery, Saint-Joseph Hospital, Paris, France †††Department of Surgery, Bicêtre University Hospital (AP-HP), Le Kremlin-Bicêtre cedex, France ‡‡‡Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, UniversityLille, Lille, France §§§Department of General and Digestive Surgery, University of Aix Marseille, Marseille, France ¶¶¶Department of Digestive and Oncological Surgery, Paoli-Calmettes Institute, Marseille, France ||||||Department of Digestive Surgery, Beauvais Hospital, Beauvais, France ****Department of General and Digestive Surgery, Strasbourg University Hospital, Strasbourg, France ††††Department of Digestive Surgery, University Hospital of Poitiers, Poitiers, France ‡‡‡‡Medical Information Department, USMR, CHU de Bordeaux-Public health pole, Bordeaux, France §§§§INSERM, ISPED, INSERM Center U897-Epidemiology-Biostatistic, Bordeaux, France ¶¶¶¶ISPED, INSERM U897 Center-Epidemiology-Biostatistic, University Bordeaux, Bordeaux, France.
Objective: To assess the effect of pelvic drainage after rectal surgery for cancer.
Background: Pelvic sepsis is one of the major complications after rectal excision for rectal cancer. Although many studies have confirmed infectiveness of drainage after colectomy, there is still a controversy after rectal surgery.
J Antimicrob Chemother
January 2017
UMR1137-IAME Inserm, Paris Diderot University, Paris, France.